Psoriasis and Sle

Summary:

Sle is found among people with Psoriasis, especially for people who are female, 40-49 old.

The study analyzes which people have Sle with Psoriasis. It is created by eHealthMe based on reports of 2,430 people who have Psoriasis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,480 drugs and 1,694 conditions by eHealthMe. Check the latest studies of Psoriasis.

What is Sle?

Sle (systemic lupus erythematosus) is found to be associated with 1,822 drugs and 1,639 conditions by eHealthMe. Check the latest studies of Sle.



On Jun, 14, 2026

2,430 people who have Psoriasis and Sle are studied.

Would you have Sle when you have Psoriasis?

Gender of people who have Psoriasis and experienced Sle *:

  • female: 93.28 %
  • male: 6.72 %

Age of people who have Psoriasis and experienced Sle *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.41000000000000003 %
  • 20-29: 1.96 %
  • 30-39: 5.38 %
  • 40-49: 44.01 %
  • 50-59: 38.63 %
  • 60+: 9.62 %

Common co-existing conditions for these people *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1,572 people, 64.69%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 798 people, 32.84%
  3. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 370 people, 15.23%
  4. Ankylosing Spondylitis (type of arthritis affecting the spine): 325 people, 13.37%
  5. Joint Pain: 182 people, 7.49%
  6. Pain: 175 people, 7.20%
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints): 132 people, 5.43%
  8. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 120 people, 4.94%
  9. Migraine (headache): 101 people, 4.16%
  10. Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 97 people, 3.99%

Common drugs taken by these people *:

  1. Humira: 1,652 people, 67.98%
  2. Remicade: 1,517 people, 62.43%
  3. Cimzia: 1,512 people, 62.22%
  4. Orencia: 1,495 people, 61.52%
  5. Arava: 1,445 people, 59.47%
  6. Simponi: 1,444 people, 59.42%
  7. Xeljanz: 1,424 people, 58.60%
  8. Enbrel: 1,395 people, 57.41%
  9. Actemra: 1,342 people, 55.23%
  10. Fosamax: 1,230 people, 50.62%

Common symptoms for these people *:

  1. Pain: 1,526 people, 62.80%
  2. Drug Ineffective: 1,483 people, 61.03%
  3. Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 1,483 people, 61.03%
  4. Hair Loss: 1,478 people, 60.82%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1,476 people, 60.74%
  6. Abdominal Discomfort: 1,430 people, 58.85%
  7. Glossodynia (a burning or painful sensation in the tongue): 1,351 people, 55.60%
  8. Swelling: 1,334 people, 54.90%
  9. Fatigue (feeling of tiredness): 1,319 people, 54.28%
  10. Synovitis (inflammation of the synovial membrane): 1,310 people, 53.91%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Sle?

- Check whether Sle is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Sle:

  • Sle (1,822 drugs)

All the conditions that are associated with Sle:

  • Sle (1,639 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Sle and Psoriasis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: